Even as smoking prevalence among adults in many high-income countries has fallen, the global burden of mortality attributed ...
The Tumaini trial is hoping to find effective vaccines against Bundibugyo virus infection, which has killed more than 5000 ...
Following a Supreme Court ruling, India's National Pharmaceutical Pricing Authority will limit trade margins on many ...
The 2026 report of the Lancet Countdown on Health and Climate Change found that climate change has become an unprecedented ...
Obstetric fistula is a devastating morbidity that rightly merits investigation and advocacy, as attempted in the World Report by Clotilde Bigot.1 However, we are dismayed by the quality of this ...
Although North Korea remains largely closed to the rest of the world, its recent state messaging suggests a shift in the country's approach to health care from long-standing isolation towards ...
Mark Dybul, a professor of Medicine at Georgetown University Medical Center and former head of the Global Fund to Fight AIDS, Tuberculosis and Malaria from 2013 to 2017, has been appointed as The ...
Clinical guidelines generally favour coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) as the revascularisation strategy of choice in patients with left main ...
In 1995, Pacific health ministers endorsed the groundbreaking Healthy Islands vision at the first Conference of Ministers of Health for the Pacific Islands in Fiji, envisioning island communities ...
Opinion
Inclusion of pregnant and lactating women in the Tumaini vaccine efficacy trial: a landmark advance
The Tumaini trial protocol (NCT07842107) developed by the National Institute of Biomedical Research of the Democratic Republic of the Congo and partners to evaluate the efficacy of vaccines against ...
Non-invasive tests (NITs) are central to clinical decision making in metabolic dysfunction-associated steatotic liver disease ...
Sickle cell disease is the most common haemoglobinopathy, affecting more than 7 million people worldwide.1 Despite substantial morbidity and mortality, access to effective disease-modifying therapies ...
Mõned tulemid on peidetud, kuna need võivad teile kättesaamatud olla.
Saate kuvada kätesaamatud tulemid